• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨髓基质细胞在免疫缺陷大鼠的液体纤维蛋白基质中进行肌腱和韧带组织工程:一项组织学研究结果

Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: results of a histologic study.

作者信息

Hankemeier Stefan, van Griensven Martijn, Ezechieli Marco, Barkhausen Tanja, Austin Matthew, Jagodzinski Michael, Meller Rupert, Bosch Ulrich, Krettek Christian, Zeichen Johannes

机构信息

Trauma Department, Hanover Medical School (MHH), Carl-Neuberg-Str 1, 30625, Hanover, Germany.

出版信息

Arch Orthop Trauma Surg. 2007 Nov;127(9):815-21. doi: 10.1007/s00402-007-0366-z. Epub 2007 Jun 14.

DOI:10.1007/s00402-007-0366-z
PMID:17569067
Abstract

INTRODUCTION

The original complex structure and mechanical properties are not fully restored after ligament and tendon injuries. Due to their high proliferation rate and differentiation potential, Bone Marrow Stromal Cells (BMSC) are considered to be an ideal cell source for tissue engineering to optimize the healing process. Ideal matrices for tissue engineering of ligaments and tendons should allow for homogenous cell seeding and offer sufficient stability.

MATERIAL AND METHODS

A mixture of human BMSC and liquid fibrin glue was injected into a standardized full-thickness window defect of the patellar tendon of immunodeficient rats (BMSC group). The histology of the tissue was analysed 10 and 20 days postoperatively and compared to four control groups. These groups consisted of a cohort with a mixture of human fibroblasts and fibrin glue, fibrin glue without cells, a defect group without treatment, and a group with uninjured patellar tendon tissue.

RESULTS

Tendon defects in the BMSC group revealed dense collagen fibres and spindle-shaped cells, which were mainly orientated along the loading axis. Histologic sections of the control groups, especially of untreated defects and of defects filled with fibrin glue only, showed irregular patterns of cell distribution, irregular formed cell nucleoli and less tissue maturation. Compared to healthy tendon tissue, higher numbers of cells and less intense matrix staining was observed in the BMSC group. No ectopic bone or cartilage formation was observed in any specimen.

CONCLUSIONS

Injection of human BMSC in a fibrin glue matrix appears to lead to more mature tissue formation with more regular patterns of cell distribution. Advantages of this "in-vivo" tissue engineering approach are a homogenous cell-matrix mixture in a well-known and approved biological matrix, and simple, minimally-invasive application by injection.

摘要

引言

韧带和肌腱损伤后,其原有的复杂结构和力学性能无法完全恢复。由于骨髓间充质干细胞(BMSC)具有较高的增殖率和分化潜能,被认为是组织工程中优化愈合过程的理想细胞来源。用于韧带和肌腱组织工程的理想基质应允许细胞均匀接种并提供足够的稳定性。

材料与方法

将人BMSC与液体纤维蛋白胶的混合物注入免疫缺陷大鼠髌腱的标准化全层窗口缺损处(BMSC组)。术后10天和20天对组织进行组织学分析,并与四个对照组进行比较。这些组包括一组人成纤维细胞与纤维蛋白胶的混合物、无细胞的纤维蛋白胶、未治疗的缺损组以及未受伤髌腱组织组。

结果

BMSC组的肌腱缺损显示出密集的胶原纤维和纺锤形细胞,主要沿负荷轴排列。对照组的组织学切片,尤其是未治疗的缺损和仅填充纤维蛋白胶的缺损,显示细胞分布不规则、细胞核仁形态不规则且组织成熟度较低。与健康肌腱组织相比,BMSC组观察到更多的细胞和较弱的基质染色。在任何标本中均未观察到异位骨或软骨形成。

结论

在纤维蛋白胶基质中注射人BMSC似乎能导致更成熟的组织形成,细胞分布模式更规则。这种“体内”组织工程方法的优点是在一种知名且已获批准的生物基质中形成均匀的细胞 - 基质混合物,并且通过注射进行简单、微创的应用。

相似文献

1
Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: results of a histologic study.人骨髓基质细胞在免疫缺陷大鼠的液体纤维蛋白基质中进行肌腱和韧带组织工程:一项组织学研究结果
Arch Orthop Trauma Surg. 2007 Nov;127(9):815-21. doi: 10.1007/s00402-007-0366-z. Epub 2007 Jun 14.
2
Bone marrow stromal cells in a liquid fibrin matrix improve the healing process of patellar tendon window defects.处于液体纤维蛋白基质中的骨髓基质细胞可改善髌腱窗缺损的愈合过程。
Tissue Eng Part A. 2009 May;15(5):1019-30. doi: 10.1089/ten.tea.2008.0046.
3
Influence of fibrin glue on proliferation and differentiation of human bone marrow stromal cells seeded on a biologic 3-dimensional matrix.纤维蛋白胶对接种于生物三维基质上的人骨髓基质细胞增殖和分化的影响。
Technol Health Care. 2008;16(2):93-101.
4
[Effect of injectable fibrin sealant compounded with bone morphogenetic protein on proliferation and differentiation of marrow stromal cells towards osteoblasts in rabbits].[注射用纤维蛋白封闭剂复合骨形态发生蛋白对兔骨髓基质细胞向成骨细胞增殖及分化的影响]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Jan;21(1):70-5.
5
Effects of chondrogenic microenvironment on construction of cartilage tissues using marrow stromal cells in vitro.软骨生成微环境对体外利用骨髓基质细胞构建软骨组织的影响。
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(5):214-21. doi: 10.1080/10731190903198723.
6
Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: a novel material for CNS tissue engineering.纤维蛋白基质为移植到损伤脊髓中的骨髓基质细胞提供了合适的支架:一种用于中枢神经系统组织工程的新型材料。
Neuropathology. 2009 Jun;29(3):248-57. doi: 10.1111/j.1440-1789.2008.00971.x. Epub 2008 Oct 20.
7
Bioactive nanofibers for fibroblastic differentiation of mesenchymal precursor cells for ligament/tendon tissue engineering applications.用于韧带/肌腱组织工程应用的间充质前体细胞成纤维细胞分化的生物活性纳米纤维。
Differentiation. 2010 Feb;79(2):102-10. doi: 10.1016/j.diff.2009.11.001. Epub 2009 Dec 5.
8
Augmentation of bone growth onto the acetabular cup surface using bone marrow stromal cells in total hip replacement surgery.在全髋关节置换术中使用骨髓基质细胞增强髋臼杯表面的骨生长。
Tissue Eng Part A. 2009 Dec;15(12):3689-96. doi: 10.1089/ten.TEA.2008.0676.
9
[Experimental study of in vitro chondrogenesis by co-culture of bone marrow stromal cells and chondrocytes].骨髓基质细胞与软骨细胞共培养体外软骨生成的实验研究
Zhonghua Yi Xue Za Zhi. 2004 Oct 17;84(20):1716-20.
10
Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments.成纤维细胞生长因子2对人骨髓基质细胞增殖和分化的调节作用:对肌腱和韧带组织工程的潜在影响
Tissue Eng. 2005 Jan-Feb;11(1-2):41-9. doi: 10.1089/ten.2005.11.41.

引用本文的文献

1
Uni-Directionally Oriented Fibro-Porous PLLA/Fibrin Bio-Hybrid Scaffold: Mechano-Morphological and Cell Studies.单向取向纤维多孔聚乳酸/纤维蛋白生物杂交支架:力学形态学与细胞研究
Pharmaceutics. 2022 Jan 25;14(2):277. doi: 10.3390/pharmaceutics14020277.
2
The effect of fibrin formulation on cell migration in an in vitro tendon repair model.纤维蛋白配方对体外肌腱修复模型中细胞迁移的影响。
J Orthop Sci. 2021 Sep;26(5):902-907. doi: 10.1016/j.jos.2020.07.017. Epub 2020 Aug 16.
3
Bone marrow mesenchymal stem cells do not enhance intra-synovial tendon healing despite engraftment and homing to niches within the synovium.
骨髓间充质干细胞尽管能归巢到滑膜内的龛位,但并不能增强滑膜内肌腱的愈合。
Stem Cell Res Ther. 2018 Jun 19;9(1):169. doi: 10.1186/s13287-018-0900-7.
4
Autologous Stem Cells in Achilles Tendinopathy (ASCAT): protocol for a phase IIA, single-centre, proof-of-concept study.跟腱病中的自体干细胞(ASCAT):一项IIA期单中心概念验证研究的方案
BMJ Open. 2018 May 14;8(5):e021600. doi: 10.1136/bmjopen-2018-021600.
5
Effect of Fibrin Formulation on Initial Strength of Tendon Repair and Migration of Bone Marrow Stromal Cells in Vitro.纤维蛋白制剂对肌腱修复初始强度及骨髓基质细胞体外迁移的影响
J Bone Joint Surg Am. 2015 Nov 4;97(21):1792-8. doi: 10.2106/JBJS.O.00292.
6
Biologics for tendon repair.用于肌腱修复的生物制剂。
Adv Drug Deliv Rev. 2015 Apr;84:222-39. doi: 10.1016/j.addr.2014.11.015. Epub 2014 Nov 21.
7
A review on the use of cell therapy in the treatment of tendon disease and injuries.细胞治疗在肌腱疾病和损伤治疗中的应用综述。
J Tissue Eng. 2014 Sep 18;5:2041731414549678. doi: 10.1177/2041731414549678. eCollection 2014.
8
Assessment of stem cell carriers for tendon tissue engineering in pre-clinical models.临床前模型中肌腱组织工程干细胞载体的评估
Stem Cell Res Ther. 2014;5(2):38. doi: 10.1186/scrt426.
9
The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair?间充质干细胞衍生的微泡在组织再生中的作用;肌腱修复的梦想?
Muscles Ligaments Tendons J. 2012 Oct 16;2(3):212-21. Print 2012 Jul.
10
Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)?人类和赛马运动员的肌腱再生:Ubi Sumus-Quo Vadimus(我们在哪里,我们要去哪里)?
Sports Med. 2012 Oct 1;42(10):871-90. doi: 10.1007/BF03262300.